Banerjee Sabyasachi, Das Avik, Bose Sankhadip, Banerjee Subhasis, Bishayee Anusha, Bishayee Anupam
Department of Pharmaceutical Chemistry, Gupta College of Technological Sciences, Asansol 713 301, West Bengal, India.
Department of Pharmacology, Gupta College of Technological Sciences, Asansol 713 301, West Bengal, India.
J Ayurveda Integr Med. 2025 Jul 30;16(5):101220. doi: 10.1016/j.jaim.2025.101220.
Barleria lupulina, a medicinal plant of India, South China and Southeast Asia, is known for its antioxidant and cytotoxic abilities. Although this plant has shown significant promise as an anticancer agent, the underlying mechanisms of action are yet to be explored.
This study aimed to assess antiproliferative and proapoptotic potential of B. lupulina leaf extract with understanding of cellular and molecular mechanisms.
The ethanolic extract was characterized using liquid chromatography-mass spectrometry and its anticancer activity was then assessed against Caco-2 colon cancer and A549 lung cancer cell lines.
Phytochemical analysis of the extract revealed the presence of acetylbarlerin, decaffeoylacteoside, gallic acid, ipolamiide, leonuriside A, shanzhiside, and vanillic acid. The extract showed concentration-dependent cytotoxicity against both cancer cells. It induced early apoptosis at lower concentrations and late apoptosis at higher concentrations. Moreover, the extract noticeably reduced reactive oxygen species and mitochondrial membrane potential in a concentration-dependent way. The Western blot and quantitative reverse transcription polymerase chain reaction showed upregulation of Bax, caspase-8, caspase-9, and cluster of differentiation 95, and downregulation of Bcl-2. Molecular docking studies revealed that decaffeoylacteoside, gallic acid, and vanillic acid exhibited dual affinities for both caspase-8 and caspase-9, while acetylbarlerin, ipolamiide, leonuriside A, and shanzhiside showed selective affinities only for caspase-9.
The ethanolic leaf extract shows significant cytotoxic and proapoptotic activities, confirming its potential as a useful resource of bioactive compounds against cancer. Nevertheless, more in-depth investigations are necessary to realize the full potential of this medicinal plant for cancer therapy.
印度、中国南方和东南亚的药用植物大花紫茉莉,以其抗氧化和细胞毒性能力而闻名。尽管这种植物作为抗癌剂已显示出巨大潜力,但其潜在作用机制尚待探索。
本研究旨在评估大花紫茉莉叶提取物的抗增殖和促凋亡潜力,并了解其细胞和分子机制。
采用液相色谱 - 质谱对乙醇提取物进行表征,然后评估其对Caco - 2结肠癌细胞和A549肺癌细胞系的抗癌活性。
提取物的植物化学分析表明存在乙酰巴雷林、去咖啡酰acteoside、没食子酸、异波拉米酰胺、益母草苷A、山栀苷和香草酸。该提取物对两种癌细胞均表现出浓度依赖性细胞毒性。它在较低浓度下诱导早期凋亡,在较高浓度下诱导晚期凋亡。此外,提取物以浓度依赖性方式显著降低活性氧和线粒体膜电位。蛋白质印迹和定量逆转录聚合酶链反应显示Bax、半胱天冬酶 - 8、半胱天冬酶 - 9和分化簇95上调,Bcl - 2下调。分子对接研究表明,去咖啡酰acteoside、没食子酸和香草酸对半胱天冬酶 - 8和半胱天冬酶 - 9均表现出双重亲和力,而乙酰巴雷林、异波拉米酰胺益母草苷A和山栀苷仅对半胱天冬酶 - 9表现出选择性亲和力。
乙醇叶提取物显示出显著的细胞毒性和促凋亡活性,证实其作为抗癌生物活性化合物有用资源的潜力。然而,要充分发挥这种药用植物在癌症治疗中的潜力,还需要更深入的研究。